Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Poseida Therapeutics stock
Learn how to easily invest in Poseida Therapeutics stock.
Poseida Therapeutics Inc is a biotechnology business based in the US. Poseida Therapeutics shares (PSTX) are listed on the NASDAQ and all prices are listed in US Dollars. Poseida Therapeutics employs 290 staff and has a trailing 12-month revenue of around $35.4 million.
How to buy shares in Poseida Therapeutics
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – PSTX – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Poseida Therapeutics stock price (NASDAQ: PSTX)Use our graph to track the performance of PSTX stocks over time.
Poseida Therapeutics shares at a glance
|Latest market close||$3.50|
|52-week range||$1.82 - $7.84|
|50-day moving average||$3.48|
|200-day moving average||$3.73|
|Wall St. target price||$16.75|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-2.32|
Buy Poseida Therapeutics shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Poseida Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Poseida Therapeutics price performance over time
|1 week (2022-09-29)||7.69%|
|1 month (2022-09-02)||0.29%|
|3 months (2022-07-06)||31.58%|
|6 months (2022-04-02)||N/A|
|1 year (2021-10-06)||-46.56%|
|2 years (2020-10-06)||-60.67%|
|3 years (2019-10-02)||N/A|
|5 years (2017-10-02)||N/A|
Poseida Therapeutics financials
|Revenue TTM||$35.4 million|
|Gross profit TTM||$31.2 million|
|Return on assets TTM||-39.04%|
|Return on equity TTM||-112.57%|
|Market capitalisation||$302.8 million|
TTM: trailing 12 months
Poseida Therapeutics share dividends
We're not expecting Poseida Therapeutics to pay a dividend over the next 12 months.
Poseida Therapeutics share price volatility
Over the last 12 months, Poseida Therapeutics's shares have ranged in value from as little as $1.82 up to $7.84. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Poseida Therapeutics's is 0.1924. This would suggest that Poseida Therapeutics's shares are less volatile than average (for this exchange).
Poseida Therapeutics overview
Poseida Therapeutics, Inc. , a clinical-stage biopharmaceutical company, focuses on developing therapeutics for patients with high unmet medical needs. The company develops P-PSMA-101, an autologous chimeric antigen receptor T cell (CAR-T) product candidate that is in Phase I trial for the treatment of patients with metastatic castrate resistant prostate cancer (mCRPC). It is also developing P-BCMA-ALLO1, which is in Phase I trial to treat patients with relapsed/refractory multiple myeloma; and P-MUC1C-ALLO1 that is in Phase I trial for treating a range of solid tumors, including breast, ovarian, and other epithelial-derived cancers. In addition, the company engages in the development of P-CD19CD20-ALLO1 for B cell malignancies and other autoimmune diseases; and P-BCMACD19-ALLO1, an allogeneic, off-the-shelf CAR-T product candidate in preclinical development for multiple myeloma. Further, it is developing P-PSMA-ALLO1, an allogeneic CAR-T product candidate for treating mCRPC. Additionally, the company engages in the development of P-OTC-101 and P-FVIII-101 that are clinical stage liver-directed gene therapies; and other allogeneic dual CAR candidates.
Poseida Therapeutics in the news
Poseida Therapeutics to Present Trial in Progress Poster for Phase 1 P-MUC1C-ALLO1 Study at the Society for Immunotherapy of Cancer Annual Meeting
Investors in Poseida Therapeutics (NASDAQ:PSTX) have unfortunately lost 58% over the last year
Poseida Therapeutics to Present at H.C. Wainwright 24th Annual Global Investment Conference
Frequently asked questionsWhat percentage of Poseida Therapeutics is owned by insiders or institutions?
Currently 29.85% of Poseida Therapeutics shares are held by insiders and 29.787% by institutions. How many people work for Poseida Therapeutics?
Latest data suggests 290 work at Poseida Therapeutics. When does the fiscal year end for Poseida Therapeutics?
Poseida Therapeutics's fiscal year ends in December. Where is Poseida Therapeutics based?
Poseida Therapeutics's address is: 9390 Towne Centre Drive, San Diego, CA, United States, 92121 What is Poseida Therapeutics's ISIN number?
Poseida Therapeutics's international securities identification number is: US73730P1084 What is Poseida Therapeutics's CUSIP number?
Poseida Therapeutics's Committee on Uniform Securities Identification Procedures number is: 35252P105
More guides on Finder
Alternatives to Webull
Looking for a discount broker like Webull that offers something different? Here are some of the top alternatives to consider.
Best renewable energy stocks for 2022
Here are the best renewable energy stocks that should be on your radar to help you grow your green portfolio
Here are 6 manganese stocks that should be on your radar as EV batteries create new demand.
The best dividend stocks for 2022
Our list of 10 dividend stocks to watch in 2022.
How to buy YanGuFang International Group (YGF) stock when it goes public
Everything we know about the YanGuFang International Group IPO, plus information on how to buy in.
What are the FAANG stocks and how do you invest in them?
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
How to buy soccer stocks
A simple guide to buying stocks in your favorite European soccer team.
How to buy Juventus stock
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
How to buy AS Roma stock
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
How to buy Borussia Dortmund stock
Steps to owning and managing BVB, with 24-hour and historical pricing before you buy.
Ask an Expert